Hydration Withdrawn Phase 4 Trials for Rosuvastatin (DB01098)

IndicationStatusPhase
DBCOND0031296 (Hydration)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03526367A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCIPrevention